Rapstrom -  Sirolimus Eluting Cobalt Chromium Coronary Stent system


Rapstrom combines the benefits of sirolimus drug to reduce restenosis and incorporate a fully biodegradable polymer that has the proven ability to reduce risk of thrombosis. Built on the Angstrom II Cobalt Chromium platform and the Vas Track stent delivery system, Rapstrom encompasses the unique hybrid stent design that facilitates trackability and usage with/through torturous anatomy. The strut thickness is maintained at the lowest dimension of 0.08 mm and along with the hybrid property of the stent, it allows for a very uniform expansion at the lesion with minimal metal-tissue surface area contact.
Visit ID (prod)